Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_assertion type Assertion NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_head.
- NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_assertion description "[Dystrophin is expressed in the non-neoplastic and benign counterparts of GIST, RMS and LMS tumors, and DMD deletions inactivate larger dystrophin isoforms, including 427-kDa dystrophin, while preserving the expression of an essential 71-kDa isoform.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_provenance.
- NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_assertion evidence source_evidence_literature NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_provenance.
- NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_assertion SIO_000772 24793134 NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_provenance.
- NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_assertion wasDerivedFrom befree-20150227 NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_provenance.
- NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_assertion wasGeneratedBy ECO_0000203 NP355651.RAQOS-2HXK4ynYgOurgi_x2n9PYTYoc76vRF33iesgo5Y130_provenance.